Intralesional Autologous Platelet Rich Plasma Injection Compared to Corticosteroid Injection for the Treatment of Chronic Plantar Fasciitis. A Prospective, Randomised, Controlled Trial.
- Conditions
- Chronic Plantar FasciitisMusculoskeletal - Other muscular and skeletal disorders
- Registration Number
- ACTRN12610000899044
- Lead Sponsor
- Dr. William Craddock
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 75
1. presenting complaint of plantar heel pain worse on rising in the morning and/or after periods of sitting or lying, which have been present for longer than 6 weeks
2. on examination, site of maximal tenderness at the attachment of the plantar fascia on the medial tubercle of the calcaneus
3. plantar fascial thickness > 4 mm at the area of maximal tenderness
4. failed conservative management of at least 4 weeks duration consisting of calf stretching, tibialis posterior and flexor hallucis longus strengthening, and the use of an off-the-shelf orthotic with heel cut-out and plantar fascial groove
1. previous injections or surgery for heel pain
2. nerve-related symptoms
3. regional pain syndrome
4. achilles tendon pathology
5. rheumatoid arthritis
6. spondyloarthropathy (incl. ankylosing spondylitis, reactive arthritis, enteropathic arthritis, and psoriatic arthritis)
7. diabetes mellitus
8. local infection
9. peripheral vascular disease
10. gout
11. coagulopathy or anti-coagulant therapy
12. pregnancy
13. dysfunction of the knee, ankle, or foot
14. work-related or compensable injury
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method